Prostate Cancer Immunotherapy is broadly divided into three categories which include therapeutic cancer vaccines, adoptive T cell therapies and checkpoint inhibitors/immune modulators.
Therapeutic cancer vaccines are targeted against tumor-associated antigens. Adoptive Cell Therapy involves enhancement of T-cells against tumor. Checkpoint inhibitors/Immune modulators are used to enhance or unleash pre-existing anti-cancer immune responses.
Related Journals of Prostate Cancer Immunotherapy
Immunotherapy: Open Access, Immunobiology journal, Immunology Journal, Immunome Research journal, Immunooncology journal, Cancer Immunology Research, Annals of Oncology, Biomed Research International, Journal of Immunotherapy of Cancer, Reviews in Urology.